Stefan H.E. Kaufmann - Immunology

Stefan H.E. Kaufmann - Immunology

Prof. Dr. Dr. h.c. Stefan H.E. Kaufmann, Director Emeritus. Founding Director of the Max Planck Institute for Infection Biology, Berlin, 1993, Director of the Department of Immunology, 1993-2019. Professor for Microbiology and Immunology, Charité University Clinics, Berlin. Faculty Fellow of the Hagler Institute for Advanced Study at Texas A & M University, College Station, Texas. Studied Biology at the University of Mainz and graduated as Ph.D. 1977. Habilitation, Free University of Berlin 1981. Positions as Staff Scientist at the Max Planck Institute for Immunobiology, Freiburg, 1982-87, Professor for Medical Microbiology and Immunology at the University of Ulm 1987-1991, Full Professor and Chair, Dept. of Immunology, University of Ulm 1991-1998. Guest Professor, Tongji University, School of Medicine, Shanghai, China (since 2011), Honorary Professor, Universidad Peruana Cayetano Heredia, Lima, Peru (since 2012), and Visiting Professor, Peking Union Medical College, Beijing, China (since 2014). Dr. h.c. University Marseille, France. Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin).

Numerous recognitions and awards. More than 900 publications with more than 65,000 citations (Google Scholar). Highly Cited Researcher (category Immunology), Thomson Institute for Scientific Information (ISI) 2001, h-index (according to J.E. Hirsch) Google Scholar: 134; Thomson/ISI: 108, amongst the 0.01% most cited scientists of ca. 7 million scientists of 22 major scientific fields globally (PLoS Biol 17(8): e3000384, 2019). Past President and Honorary Member of the German Society for Immunology (DGfI). Past President of the European Federation of Immunological Societies (EFIS). Past President of the International Union of Immunological Societies (IUIS). Member of Berlin-Brandenburg Academy of Sciences and Humanities  (BBAW), German National Academy of Sciences Leopoldina (Leopoldina), European Molecular Biology Organization (EMBO), American Academy of Microbiology (ASM Academy) and others. Board member of the Global Alliance for Vaccines and Immunization (GAVI), 2010 to 2013. From 2009 to 2014 member of the Scientific Board of the Global Alliance for TB Drug Development (TB Alliance). Member of the Strategic Advisory Committee of the European and Developing Countries Clinical Trials Partnership (EDCTP), 2014 to 2018. Member of the Executive Committee of Robert Koch Foundation, 2003 to 2019. Chair of the Board of Schering Foundation. Member of the Scientific Advisory Board and member of the Board of Trustees of Lindau Nobel Laureate Meetings. Co-Chair of the Scientific Committee of World Health Summit. Hobby: Collector of historical medical books (Cicero article).

 

 

Main Fields of Interest

  • Role of cytokines and T cell populations in immunity against intracellular bacteria
  • Regulation and memory in immunity to intracellular bacteria
  • Innate immune response to intracellular bacteria
  • Mucosal immunity and mucosal vaccination
  • Regulatory RNA
  • Systems biology of tuberculosis
  • Systems vaccinology
  • Rational design of a vaccine against tuberculosis
  • Biomarkers of susceptibility/resistance in tuberculosis
  • High-Impact Project ADITEC
  • Infect-ERA Project ABIR
  • Collaborative Project TANDEM

  • GC6-2013: Protective Biomarkers of Risk of TB
  • Joint Undertaking: Biomarkers for enhanced vaccine immunosafety BioVacSafe
  • Joint Undertaking: Model-based preclinical development of anti-tuberculosis drug combinations PreDICT-TB

BMBF

  • Infect Control 2020: Neue Antiinfektionsstrategien (New Anti-infection Strategies) Project
Go to Editor View